QA: Indaptus Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001857044_2026_Indaptus_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001857044, Indaptus Therapeutics Inc

  xvar xval
0 AssetsCurrent 9,310,168
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 6,158,575
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,221,522
9 ResearchAndDevelopmentExpense 12,095,433
10 remainder_Expenses 0
11 remainder_Revenues 138,018
12 remainder_NetIncome -8,583,511
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 9,310,168
1 Liabilities 6,158,575
2 Expenses 24,316,955
3 Revenues 138,018
4 StockholdersEquity 3,151,593
5 NetIncome -32,762,448
6 ComprehensiveNetIncome -32,762,448
7 BaseVar 24,253,614
8 EconomicCapitalRatiobeforeLimitedLiability -3.35
9 EconomicCapitalRatio 0.575

Edgar->Model Mapping

Feature Distribution

Change over Time